Hepatitis b virus suppresses complement c9 synthesis by limiting the availability of transcription factor usf-1 and inhibits formation of membrane attack complex: implications in disease pathogenesis

HIGHLIGHTS

• who: Ayana Baidya from the Centre for Liver Research, School of Digestive and Liver Diseases, Institute Bose Road, Kolkata, India have published the Article: Hepatitis B virus suppresses complement C9 synthesis by limiting the availability of transcription factor USF-1 and inhibits formation of membrane attack complex: implications in disease pathogenesis, in the Journal: (JOURNAL) of 30/05/2022
• what: MAC is the principal innate immune effector of the complement terminal pathway and this study provides novel insights into the mechanism by which HBV attenuates the expression of C9, the major constituent of MAC, and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.